Anca Askanase
Chair of the Department of Medicine, Hospital for Special Surgery · New York Presbyterian Hospital
Credentials: · · · ·
History
- Present
Division of Rheumatology · New York Presbyterian Hospital
- 1994–1997
St. Luke's/Roosevelt Hospital New York
- 1985–1989
University of Medicine and Pharmacy "Grigore T. Popa" Romania
Research
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
New England Journal of Medicine · 2020 · 1,025 citations
Combined oral contraceptives in women with systemic lupus erythematosus
New England Journal of Medicine · 2005 · 895 citations
Annals of Internal Medicine · 2005 · 495 citations
- CA
60 papers
58 papers
57 papers
- JM
56 papers
- DW
53 papers
52 papers
52 papers
50 papers
Clinical trials
- 2024–2040
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
Principal investigator · Enrolling by invitation · Phase 1
Hospital for Special Surgery, New York
- 2020–2021
Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID
Principal investigator · Terminated · Phase 2
Columbia University
- 2014–2024
ACTHar in the Treatment of Lupus Nephritis
Principal investigator · Terminated · Phase 4
Columbia University
- 2022–2028
VIBRANT: VIB4920 for Active Lupus Nephritis
Site PI · Recruiting · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)